Join PharmScript, LLC. on Wednesday, April 29, from 1:00 to 2:00 p.m. EDT. Sarah Ragone, Vice President of Clinical Reimbursement / Education & Training at Coretactics, Inc., will present the webinar.
New CMS guidance reinforces the importance of thorough assessment, accurate diagnoses, documented non-pharmacologic interventions, and careful stewardship of antipsychotic medications within a broader behavior management framework.
This program aims to reduce unnecessary psychotropic medication use, ensure accurate reporting, strengthen compliance with CMS regulations, and support high-quality behavioral health care for long-stay residents.
Learning objectives:
- Understand the negative impact of poor behavior management on your quality outcomes.
- Ensure psychotropic medications are used only when clinically appropriate, following CMS guidance under F605 to prevent unnecessary chemical restraint.
- Update internal tracking systems to account for the new hybrid QM design.
- Assist facility leadership in training staff to recognize and respond to behaviors as expressions of unmet needs, incorporating trauma‑informed care, environmental modifications, meaningful engagement, and individualized support strategies.
The webinar is approved for 1.00 CEU credit for nursing home administrators, nurses, and directors of nursing.
Register today: click here.